Shares in Novo Nordisk (NYSE:NVO) fell 2.5% to DKK319.20 after Deutsche Bank pointed to a continued slowdown in the oral ...

MOVE over fat jabs – there’s a new weight loss ‘wonder’ in town. The Wegovy tablet is now officially on sale in the UK, ...

This is the list for you if you are looking for dividend stocks with attractive yields and well-supported dividends.

Kailera Therapeutics Inc. (NASDAQ:KLRA) is one of the best IPO stocks with huge upside potential. On July 7, Kailera ...

Goldman Sachs has picked Piramal Pharma, Syngene and Divi's as its preferred pharma bets ahead of Q1FY27 earnings while warning that margin pressure and fading Revlimid gains could weigh on several ...

GLP-1 medications, such as those prescribed for weight loss, have become well known for helping people lose significant amounts of weight. But researchers are beginning to ask whether the effects ...

Drug stocks got hit hard on Monday in what Jim Cramer called a “vicious rotation,” and the selloff looked like the usual crowded-trade unwind. Investors decided the Mounjaro story was played out. On ...

Fresh fruits and vegetables are no longer relegated to garnish, add-ins, or supporting roles on restaurant plates.

In a position statement published earlier this year, the American College of Clinical Pharmacy called for the total ...

Want to add a little pep to your weight-loss journey? Incorporate peptides into your routine, say an increasing number of ...

Investment chief Tom King is applying what he learnt from winning a sailing gold medal in the Sydney Olympics to navigating ...

Lineage remains a Buy, offering a margin of safety and re-rating potential despite near-term macro and operational headwinds.